Wockhardt has raised Rs 50 crore through the allotment of 5,000 Nos. of Unlisted, Rated, Secured Non-Convertible Debentures (NCDs) of face value of Rs 1,00,000 each to Centrum Credit Opportunities Trust on private placement basis on the terms and conditions as stipulated in the amended and restated debenture trust deed and other transaction documents dated October 20, 2021. The Credit Facilities Committee of the Board of Directors of the company, at its meeting held on October 21, 2021, has allotted the same.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: